Regarding the imaging, clinical presentation, and management of giant cell tumor (GCT) of bone, all of the following statements are correct EXCEPT:

Explanation

## Imaging, Presentation, and Management of Giant Cell Tumor ### Correct Statements (Options 0, 1, 2) **Option 0 — Radiographic appearance:** GCT presents as a **well-demarcated, purely lytic lesion** with characteristic: - **Soap-bubble** or **honeycomb** pattern (multilocular) - Eccentric location in the epiphysis - Extension to the articular surface (subchondral) - No sclerotic rim or periosteal reaction (benign) **Option 1 — Common sites:** GCT shows a strong predilection for the **knee joint** (50–65% of cases): - **Distal femur** (most common single site) - **Proximal tibia** (second most common) - Other sites: distal radius, proximal humerus, sacrum **Option 2 — Pulmonary metastases:** A unique feature of GCT is the occurrence of **benign pulmonary metastases** in ~1–2% of cases, even when the primary tumor is histologically benign. These are: - Usually discovered years after primary surgery - Often asymptomatic and slow-growing - Rarely fatal; may regress spontaneously - Thought to represent embolic seeding during surgery **High-Yield:** Pulmonary metastases from benign GCT are a pathognomonic finding — no other benign bone tumor metastasizes. ### FALSE Statement (Option 3 — The Correct Answer) **Warning:** Intralesional curettage **alone** has a **recurrence rate of 40–65%**, NOT a cure rate >90%. This is a critical trap. **Key Point:** Modern management of GCT requires: | Treatment | Recurrence Rate | Indications | |-----------|-----------------|-------------| | Curettage alone | 40–65% | Rarely used now | | Curettage + phenol | 10–20% | Standard adjuvant | | Curettage + liquid nitrogen | 5–15% | Aggressive tumors | | Curettage + cement | 10–20% | Alternative adjuvant | | Wide excision | <5% | Large/recurrent/aggressive | **Clinical Pearl:** The **adjuvant modality** (phenol, liquid nitrogen, or cement) is essential to reduce recurrence. Phenol is most commonly used due to safety and efficacy. Radiation therapy is **avoided** in modern practice due to the risk of malignant transformation. **Mnemonic for GCT management:** **PACE** - **P**henol (or liquid nitrogen/cement) — adjuvant - **A**djuvant reduces recurrence to <20% - **C**urettage is the primary technique - **E**xcision (wide) reserved for recurrent/aggressive cases ## GCT Management Algorithm ```mermaid flowchart TD A[Giant Cell Tumor diagnosed]:::outcome --> B[Assess size and location]:::decision B -->|Small, accessible| C[Intralesional curettage + adjuvant]:::action B -->|Large or recurrent| D[Wide excision]:::action C --> E[Phenol/liquid nitrogen/cement]:::action E --> F[Recurrence rate 10-20%]:::outcome D --> G[Recurrence rate <5%]:::outcome H[Avoid radiation]:::urgent style H fill:#ffcccc ```